Table 1. Patient characteristics (n = 733).
| Characteristic | Number (%) |
| Age, median (IQR) | 44 (36, 56) |
| Sex (male), n (%) | 680 (92.8%) |
| HIV infection route, n (%) | |
| MSM | 461 (62.9%) |
| Heterosexual | 133 (18.1%) |
| Hemophilia | 123 (16.8%) |
| Drug use | 2 (0.3%) |
| Unknown | 14 (1.9%) |
| CD4+ cell count, median (IQR) (cells/μL) | 234 (97, 399) |
| ≥200 | 407 (55.5%) |
| 100–199 | 138 (18.8%) |
| <100 | 188 (26.7%) |
| HIV-RNA VL, median (IQR) (copies/mL) | <40 (<40, 23000) |
| ≤40 (normal range) | 386 (52.7%) |
| 40<VL≤10,000 | 136 (18.6%) |
| 10,000<VL≤100,000 | 99 (13.5%) |
| 100,000< VL | 112 (15.3%) |
| History of HAART, n (%) | 545 (74.4%) |
| With GI symptoms, n (%) | 263 (35.9%) |
Abbreviations: MSM, men who have sex with men; IQR, interquartile range; VL, viral load; HAART, highly active anti-retroviral therapy; GI, gastrointestinal.